promising ovarian cancer drug trial
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

Promising ovarian cancer drug trial

Arab Today, arab today

Arab Today, arab today Promising ovarian cancer drug trial

Bloomington -UPI

An experimental two-drug combination to treat late-stage ovarian cancer is producing strong results, Indiana University researchers say. Kenneth Nephew, a cancer researcher in the Indiana University Medical Sciences Program-Bloomington, says a surprising 70 percent of patients in the phase II trial show a positive effect from the new therapy. The researchers say they may have discovered biomarkers that could help identify women who would respond best to the therapy. "The potential that this regimen is efficacious, combining decitabine with the carboplatin therapy, is very exciting," Nephew says in a statement. "It's well tolerated and didn't have any dose-limiting toxicities. We could enroll patients with confidence because of these results." Lead investigator Dr. Daniela Matei, an oncologist and associate professor of medicine at the Indiana University School of Medicine, says the women in this phase II study had already undergone other experimental therapies once their cancer had become resistant to carboplatin, so the high rate of women experiencing a positive effect from their carboplatin-decitabine combo was surprising, as was the number of women who remained in remission after six months.

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

promising ovarian cancer drug trial promising ovarian cancer drug trial

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

promising ovarian cancer drug trial promising ovarian cancer drug trial

 



GMT 09:37 2012 Saturday ,28 April

Asamoah Gyan celebrates UAE title

GMT 06:57 2017 Tuesday ,12 December

Latest Grateful Dead resurrection -- a duo

GMT 14:03 2017 Friday ,10 February

3 Chinese miners killed in accident in Albania

GMT 10:06 2018 Sunday ,14 January

Qanso, Kijian tackle recent developments

GMT 18:58 2017 Saturday ,04 March

Gold prices continue to fall

GMT 12:49 2017 Thursday ,24 August

Fadl Shaker could be arrested soon

GMT 02:06 2017 Monday ,30 October

May22/Jun21

GMT 22:28 2017 Thursday ,24 August

February20th-March20th

GMT 08:07 2017 Saturday ,18 November

BBA President visits BHA

GMT 02:27 2017 Saturday ,28 October

September24th-October23rd

GMT 14:20 2017 Saturday ,26 August

Former VW engineer gets 40 months
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday